Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by Schizophrenia and Bipolar Disorder and controls

Psychiatry Research

Volumn 228, Issue 3, 2015, Pages 945-949

  Marco, Calabrò ^a,b,c   Antonio, Drago ^e   Antonina, Sidoti ^c   Alessandro, Serretti ^d   Concetta, Crisafulli ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Pathway analysis; Pruning; Schizophrenia

Indexed keywords

ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; GENE; GENETIC ANALYSIS; HLA C GENE; HLA DRA GENE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPTIC PRUNING; SYNAPTIC TRANSMISSION; ADULT; FEMALE; GENE REGULATORY NETWORK; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; NERVE CELL PLASTICITY;

ADULT; BIPOLAR DISORDER; FEMALE; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INFLAMMATION; INTERNATIONALITY; MALE; MIDDLE AGED; NEURONAL PLASTICITY; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84938746414     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.06.013     Document Type: Article

References (53)

1. Alliot F., Godin I., Pessac B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res. Dev. Brain Res. 1999, 117(2):145-152.
2. Amital H., Shoenfeld Y. Autoimmunity and schizophrenia: an epiphenomenon or an etiology?. Isr. J. Med. Sci. 1993, 29(9):593-597.
3. Axelsson R., Martensson E., Alling C. Impairment of the blood-brain barrier as an aetiological factor in paranoid psychosis. Br. J. Psychiatry 1982, 141:273-281.
4. Beers M.H., Berkow R. Psychiatric Emergencies, The Merck Manual of Diagnosis and Therapy 2004, Merck Research Laboratories, Whitehouse Station, NJ.
5. Cantor R.M., Lange K., Sinsheimer J.S. Prioritizing GWAS results: a review of statistical methods and recommendations for their application. Am. J. Hum. Genet. 2010, 86(1):6-22.
6. Cross-Disorder Group of the Psychiatric Genomics C. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381(9875):1371-1379.
7. Debnath M., Cannon D.M., Venkatasubramanian G. Variation in the major histocompatibility complex [MHC] gene family in schizophrenia: associations and functional implications. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 42:49-62.
8. Drago A., Giegling I., Schafer M., Hartmann A.M., Konte B., Friedl M., Serretti A., Rujescu D. Genome-wide association study supports the role of the immunological system and of the neurodevelopmental processes in response to haloperidol treatment. Pharmacogenet. Genomics 2014, 24(6):314-319.
9. Faissner A., Pyka M., Geissler M., Sobik T., Frischknecht R., Gundelfinger E.D., Seidenbecher C. Contributions of astrocytes to synapse formation and maturation-Potential functions of the perisynaptic extracellular matrix. Brain Res. Rev. 2010, 63(1-2):26-38.
10. Fourgeaud L., Boulanger L.M. Role of immune molecules in the establishment and plasticity of glutamatergic synapses. Eur. J. Neurosci. 2010, 32(2):207-217.
11. Gilvarry C.M., Sham P.C., Jones P.B., Cannon M., Wright P., Lewis S.W., Bebbington P., Toone B.K., Murray R.M. Family history of autoimmune diseases in psychosis. Schizophr. Res. 1996, 19(1):33-40.
12. Hosak L., Silhan P., Hosakova J. Genome-wide association studies in schizophrenia, and potential etiological and functional implications of their results. Acta Med. (Hradec Kralove) 2012, 55(1):3-11.
13. Howie B.N., Donnelly P., Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009, 5(6):e1000529.
14. International Schizophrenia C., Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460(7256):748-752.
15. Ivleva E.I., Morris D.W., Moates A.F., Suppes T., Thaker G.K., Tamminga C.A. Genetics and intermediate phenotypes of the schizophrenia--bipolar disorder boundary. Neurosci. Biobehav. Rev. 2010, 34(6):897-921.
16. Karanikas E.P. [Psycho-immunological mechanisms in schizophrenia]. Psychiatriki 2011, 22(1):43-52.
17. Krause D., Wagner J., Matz J., Weidinger E., Obermeier M., Riedel M., Gruber R., Schwarz M., Mueller N. Monocytic HLA DR antigens in schizophrenic patients. Neurosci. Res. 2012, 72(1):87-93.
18. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19(8):312-318.
19. Li T., Li Z., Chen P., Zhao Q., Wang T., Huang K., Li J., Li Y., Liu J., Zeng Z., Feng G., He L., Shi Y. Common variants in major histocompatibility complex region and TCF4 gene are significantly associated with schizophrenia in Han Chinese. Biol. Psychiatry 2010, 68(7):671-673.
20. Marchini J., Howie B., Myers S., McVean G., Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 2007, 39(7):906-913.
21. Modrego P.J., Ferrandez J. Familial multiple sclerosis with repetitive relapses of manic psychosis in two patients (mother and daughter). Behav. Neurol. 2000, 12(4):175-179.
22. Muller N., Riedel M., Ackenheil M., Schwarz M.J. The role of immune function in schizophrenia: an overview. Eur. Arch. Psychiatry Clin. Neurosci. 1999, 249(Suppl 4):62-68.
23. Muller N., Riedel M., Hadjamu M., Schwarz M.J., Ackenheil M., Gruber R. Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophrenia. Am. J. Psychiatry 1999, 156(4):634-636.
24. O'Connell G., Lawrie S.M., McIntosh A.M., Hall J. Schizophrenia risk genes: Implications for future drug development and discovery. Biochem. Pharmacol. 2011, 81(12):1367-1373.
25. O'Keefe G.M., Nguyen V.T., Benveniste E.N. Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases. J. Neurovirol. 2002, 8(6):496-512.
26. Paus T., Keshavan M., Giedd J.N. Why do many psychiatric disorders emerge during adolescence?. Nat. Rev. Neurosci. 2008, 9(12):947-957.
27. Phipson B., Smyth G.K. Permutation P-values should never be zero: calculating exact P-values when permutations are randomly drawn. Stat. Appl. Genet. Mol. Biol. 2010, 9. Article39.
28. Pont-Lezica L., Bechade C., Belarif-Cantaut Y., Pascual O., Bessis A. Physiological roles of microglia during development. J. Neurochem. 2011, 119(5):901-908.
29. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81(3):559-575.
30. R Core Team, 2014. R: A Language and Environment for Statistical Computing.
31. Rothermundt M., Arolt V., Bayer T.A. Review of immunological and immunopathological findings in schizophrenia. Brain. Behav. Immunol. 2001, 15(4):319-339.
32. Rujescu D., Ingason A., Cichon S., Pietilainen O.P., Barnes M.R., Toulopoulou T., Picchioni M., Vassos E., Ettinger U., Bramon E., Murray R., Ruggeri M., Tosato S., Bonetto C., Steinberg S., Sigurdsson E., Sigmundsson T., Petursson H., Gylfason A., Olason P.I., Hardarsson G., Jonsdottir G.A., Gustafsson O., Fossdal R., Giegling I., Moller H.J., Hartmann A.M., Hoffmann P., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Djurovic S., Melle I., Andreassen O.A., Hansen T., Werge T., Kiemeney L.A., Franke B., Veltman J., Buizer-Voskamp J.E., Investigators G., Sabatti C., Ophoff R.A., Rietschel M., Nothen M.M., Stefansson K., Peltonen L., St Clair D., Stefansson H., Collier D.A. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum. Mol. Genet. 2009, 18(5):988-996.
33. Ruutiainen J., Arnadottir T., Molnar G., Salmi A., Frey H. Myelin basic protein antibodies in the serum and CSF of multiple sclerosis and subacute sclerosing panencephalitis patients. Acta Neurol. Scand. 1981, 64(3):196-206.
34. Saetre P., Emilsson L., Axelsson E., Kreuger J., Lindholm E., Jazin E. Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry 2007, 7:46.
35. Saito R., Smoot M.E., Ono K., Ruscheinski J., Wang P.L., Lotia S., Pico A.R., Bader G.D., Ideker T. A travel guide to Cytoscape plugins. Nat. Methods 2012, 9(11):1069-1076.
36. Schizophrenia Psychiatric Genome-Wide Association Study C. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43(10):969-976.
37. Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511(7510):421-427.
38. Schmitt A., Hasan A., Gruber O., Falkai P. Schizophrenia as a disorder of disconnectivity. Eur. Arch. Psychiatry Clin. Neurosci. 2011, 261(Suppl 2):S150-S154.
39. Schwarz M.J., Riedel M., Ackenheil M., Muller N. Decreased levels of soluble intercellular adhesion molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients. Biol. Psychiatry 2000, 47(1):29-33.
40. Sequeira P.A., Martin M.V., Vawter M.P. The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol. Dis. 2012, 45(1):23-36.
41. Shao L., Vawter M.P. Shared gene expression alterations in schizophrenia and bipolar disorder. Biol. Psychiatry 2008, 64(2):89-97.
42. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460(7256):753-757.
43. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietilainen O.P., Mors O., Mortensen P.B., Sigurdsson E., Gustafsson O., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Suvisaari J., Lonnqvist J., Paunio T., Borglum A.D., Hartmann A., Fink-Jensen A., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Bottcher Y., Olesen J., Breuer R., Moller H.J., Giegling I., Rasmussen H.B., Timm S., Mattheisen M., Bitter I., Rethelyi J.M., Magnusdottir B.B., Sigmundsson T., Olason P., Masson G., Gulcher J.R., Haraldsson M., Fossdal R., Thorgeirsson T.E., Thorsteinsdottir U., Ruggeri M., Tosato S., Franke B., Strengman E., Kiemeney L.A., Genetic R., Outcome in P., Melle I., Djurovic S., Abramova L., Kaleda V., Sanjuan J., de Frutos R., Bramon E., Vassos E., Fraser G., Ettinger U., Picchioni M., Walker N., Toulopoulou T., Need A.C., Ge D., Yoon J.L., Shianna K.V., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Carracedo A., Arango C., Costas J., Jonsson E.G., Terenius L., Agartz I., Petursson H., Nothen M.M., Rietschel M., Matthews P.M., Muglia P., Peltonen L., St Clair D., Goldstein D.B., Stefansson K., Collier D.A. Common variants conferring risk of schizophrenia. Nature 2009, 460(7256):744-747.
44. Stephan A.H., Barres B.A., Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci. 2012, 35:369-389.
45. Strakowski S.M., Adler C.M., Almeida J., Altshuler L.L., Blumberg H.P., Chang K.D., DelBello M.P., Frangou S., McIntosh A., Phillips M.L., Sussman J.E., Townsend J.D. The functional neuroanatomy of bipolar disorder: a consensus model. Bipolar Disord. 2012, 14(4):313-325.
46. Strous R.D., Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J. Autoimmun. 2006, 27(2):71-80.
47. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 2003, 60(12):1187-1192.
48. Tian L., Ma L., Kaarela T., Li Z. Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases. J. Neuroinflamm. 2012, 9:155.
49. Walker R.M., Christoforou A., Thomson P.A., McGhee K.A., Maclean A., Muhleisen T.W., Strohmaier J., Nieratschker V., Nothen M.M., Rietschel M., Cichon S., Morris S.W., Jilani O., Stclair D., Blackwood D.H., Muir W.J., Porteous D.J., Evans K.L. Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorder. Neurosci. Lett. 2010, 478(1):9-13.
50. Warde-Farley D., Donaldson S.L., Comes O., Zuberi K., Badrawi R., Chao P., Franz M., Grouios C., Kazi F., Lopes C.T., Maitland A., Mostafavi S., Montojo J., Shao Q., Wright G., Bader G.D., Morris Q. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010, 38(Web Server issue):W214-W220.
51. Wierzba-Bobrowicz T., Lewandowska E., Lechowicz W., Stepien T., Pasennik E. Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics. Folia Neuropathol. 2005, 43(2):81-89.
52. Williams H.J., Norton N., Dwyer S., Moskvina V., Nikolov I., Carroll L., Georgieva L., Williams N.M., Morris D.W., Quinn E.M., Giegling I., Ikeda M., Wood J., Lencz T., Hultman C., Lichtenstein P., Thiselton D., Maher B.S., Molecular Genetics of Schizophrenia Collaboration International Schizophrenia Consortium S.-P.G., Malhotra A.K., Riley B., Kendler K.S., Gill M., Sullivan P., Sklar P., Purcell S., Nimgaonkar V.L., Kirov G., Holmans P., Corvin A., Rujescu D., Craddock N., Owen M.J., O'Donovan M.C. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol. Psychiatry 2011, 16(4):429-441.
53. Zuberi K., Franz M., Rodriguez H., Montojo J., Lopes C.T., Bader G.D., Morris Q. GeneMANIA prediction server 2013 update. Nucleic Acids Res. 2013, 41(Web Server issue):W115-W122.